Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

An exploration of how broadly neutralizing antibodies might induce HIV remission: the 'vaccinal' effect.

Journal article

Tipoe T. et al, (2022), Current opinion in HIV and AIDS, 17, 162 - 170

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Journal article

Ogbe A. et al, (2022), JCI Insight, 7

Divergent trajectories of antiviral memory after SARS-CoV-2 infection.

Journal article

Tomic A. et al, (2022), Nature communications, 13

Immunotherapeutic approaches to HIV cure and remission

Journal article

Lee MJ. et al, (2022), Current Opinion in Infectious Diseases, 35, 31 - 41

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Journal article

Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15

Human MAIT cells respond to and suppress HIV-1.

Journal article

Phetsouphanh C. et al, (2021), eLife, 10

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

Journal article

Townsend A. et al, (2021), Nature Communications, 12

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Journal article

Payne RP. et al, (2021), Cell, 184, 5699 - 5714.e11

Tolerability of four-drug antiretroviral combination therapy in primary HIV-1 infection.

Journal article

Burns JE. et al, (2021), HIV medicine, 22, 770 - 774

Load More